301 related articles for article (PubMed ID: 26142548)
1. An abnormally high expression of ISL-1 represents a potential prognostic factor in gastric cancer.
Guo C; Wang W; Shi Q; Chen P; Zhou C
Hum Pathol; 2015 Sep; 46(9):1282-9. PubMed ID: 26142548
[TBL] [Abstract][Full Text] [Related]
2. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
4. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
[TBL] [Abstract][Full Text] [Related]
5. AKR1B10, a good prognostic indicator in gastric cancer.
Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS
Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance.
Zhao ZS; Chu YQ; Ye ZY; Wang YY; Tao HQ
Hum Pathol; 2010 May; 41(5):686-96. PubMed ID: 20060156
[TBL] [Abstract][Full Text] [Related]
7. Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma.
Zhao P; Lu Y; Liu L
Int J Clin Exp Pathol; 2015; 8(5):5230-5. PubMed ID: 26191222
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.
Yang Q; Zhang C; Huang B; Li H; Zhang R; Huang Y; Wang J
Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):953-7. PubMed ID: 23751352
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
10. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
12. Multivariate prognostic study on node-positive gastric cancer: is tumor size a prognostic indicator?
Liu Y; Chen XH; Meng XH; Liu CF; Zhao LL; Han JW; Zhuang LW
Hepatogastroenterology; 2012; 59(114):623-6. PubMed ID: 22024039
[TBL] [Abstract][Full Text] [Related]
13. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W
Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328
[TBL] [Abstract][Full Text] [Related]
15. HER2 status in unusual histological variants of gastric adenocarcinomas.
Giuffrè G; Ieni A; Barresi V; Caruso RA; Tuccari G
J Clin Pathol; 2012 Mar; 65(3):237-41. PubMed ID: 22067088
[TBL] [Abstract][Full Text] [Related]
16. Reduced Krüppel-like factor 17 (KLF17) expression correlates with poor survival in patients with gastric cancer.
Peng JJ; Wu B; Xiao XB; Shao YS; Feng Y; Yin MX
Arch Med Res; 2014 Jul; 45(5):394-9. PubMed ID: 24947617
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
[TBL] [Abstract][Full Text] [Related]
18. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
[TBL] [Abstract][Full Text] [Related]
20. The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.
Lu G; Zhou L; Zhang X; Zhu B; Wu S; Song W; Gong X; Wang D; Tao Y
World J Surg Oncol; 2016 Oct; 14(1):276. PubMed ID: 27793161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
